Evidence map›Paper›PMID 26322670›Full record

Observational studyJournal of acquired immune deficiency syndromes (1999)2015

Brief Report: Impact of Option B+ on the Infant PMTCT Cascade in Lilongwe, Malawi.

Maria H Kim, Saeed Ahmed, Mina C Hosseinipour, Xiaoying Yu, Chi Nguyen, Frank Chimbwandira, Mary E Paul, Peter N Kazembe, Elaine J Abrams

Abstract readObservational Study
In one paragraph

Observational study in Journal of acquired immune deficiency syndromes (1999), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Maria H Kim*Baylor College of Medicine International Pediatric AIDS Initiative at Texas Children's Hospital, Houston, TX; †Baylor College of Medicine-Abbott Fund Children's Clinical Center of Excellence, Lilongwe, Malawi; ‡UNC Project, Lilongwe, Malawi; §University of North Carolina School of Medicine, Chapel Hill, NC; ‖Department of Pediatrics, Epidemiology Center, Baylor College of Medicine, Houston, TX; ¶Department of HIV and AIDS, Ministry of Health, Lilongwe, Malawi; #ICAP-Columbia University, Mailman School of Public Health, New York, NY; and **College of Physicians and Surgeons, Columbia University, New York, NY.
Saeed Ahmed
Mina C Hosseinipour
Xiaoying Yu
Chi Nguyen
Frank Chimbwandira
Mary E Paul
Peter N Kazembe
Elaine J Abrams

Funding

Virology CoreP30AI036211 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI KOZINETZ, CLAUDIA A. · 1994 to 2015
$21.7M
Improving prevention of mother-to-child HIV transmission outcomes in MalawiK01TW009644 · FIC · BAYLOR COLLEGE OF MEDICINE · PI KIM, MARIA HYOUN · 2013 to 2017
$663k
FIC NIH HHS K01 TW009644NIAID NIH HHS P30 AI036211NIAID NIH HHS P30-AI36211
6 · The paper itself

Abstract

This observational study compared uptake of infant prevention of mother-to-child transmission of HIV services pre/post implementation of Option B+ in Lilongwe, Malawi. There were 845 (pre) and 998 (post) births. Post-B+, infants had longer median predelivery maternal antiretroviral therapy {62 days [interquartile range (IQR): 38-94] pre-B+ vs. 95 days [IQR: 61-131] post-B+; P < 0.0001} and improved polymerase chain reaction testing (82.0% vs. 86.5%; P = 0.01) at younger median age [7.6 weeks (IQR: 6.6-10.9) vs. 6.9 (IQR: 6.4-8.1); P < 0.0001]. Proportion testing polymerase chain reaction positive decreased (4.6% vs. 2.6%; P = 0.03). Proportion of HIV-infected infants starting antiretroviral therapy (75% vs. 77.3%) and age at initiation [19.7 weeks (IQR: 15.4-31.1) vs. 16 (IQR: 13.3-17.9)] remained unchanged. These findings suggest modest improvements in infant care with Option B+.

Indexed as

AdultAnti-Retroviral AgentsChemopreventionFemaleHIV InfectionsHumansInfantInfant, NewbornInfectious Disease Transmission, VerticalMalawiMalePregnancyTreatment OutcomeAnti-Retroviral Agents

Identifiers

PMID26322670
PMCPMC4537054

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.